Smoller David Adam 4
4 · SIGMA ALDRICH CORP · Filed Feb 15, 2012
Insider Transaction Report
Form 4
Smoller David Adam
President, Research Biotech
Transactions
- Award
ISO Stock Option Right To Buy
2012-02-14$70.32/sh+1,422$99,995→ 1,422 totalExercise: $70.32From: 2013-02-14Exp: 2022-02-14→ Common Stock (1,422 underlying) - Award
NQ Stock Option, Right To Buy
2012-02-14$70.32/sh+16,078$1,130,605→ 16,078 totalExercise: $70.32From: 2013-02-14Exp: 2022-02-14→ Common Stock (16,078 underlying) - Award
Common Stock
2012-02-13+2,816→ 10,945 total - Exercise/Conversion
NQ Stock Option, Right to Buy
2012-02-14−8,000→ 13,943 totalExercise: $48.61From: 2011-02-16Exp: 2020-02-16→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2012-02-14$52.76/sh+4,283$225,971→ 15,228 total - Exercise/Conversion
Common Stock
2012-02-14$48.61/sh+8,000$388,880→ 23,228 total - Exercise/Conversion
NQ Stock Option Right To Buy
2012-02-14−4,283→ 0 totalExercise: $52.76From: 2009-02-15Exp: 2018-02-15→ Common Stock (4,283 underlying) - Sale
Common Stock
2012-02-14$70.15/sh−12,283$861,683→ 10,945 total
Footnotes (2)
- [F1]The options vest in three equal installments beginning on February 14, 2013.
- [F2]The options vested in three equal installments on February 15, 2009, 2010, 2011.